Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy

Manuscript Number: 

15-1028R2

Author(s): 
Christine M. Baugh, Robert C. Cantu, Christine Chaisson, Nathan G. Fritts, Cicek Gercel-Taylor, Tsuneya Ikezu, James A. Joyce, Brett Martin, Sahil Shah, Robert Stern, Douglas D. Taylor, Yorghos Tripodis, Jing Zhang

Disclosures

Christine M. Baugh

  • Grants
    • Agency: 
      National Football League Players' Association
      Dates: 
      November 1, 2015 - Present
    • Agency: 
      National Collegiate Athletic Association
      Dates: 
      January 1, 2015 - December 30, 2015

Robert C. Cantu

  • Consulting Fees:
    Robert C. Cantu is a paid consultant to the NFL Head Neck and Spine Committee, NOCSAE, Concussion Legacy Foundation, receives royalties from book publications, and compensation from expert legal opinion.
    Patents/Royalties
    Robert C. Cantu is a paid consultant to the NFL Head Neck and Spine Committee, NOCSAE, Concussion Legacy Foundation, receives royalties from book publications, and compensation from expert legal opinion.

Christine Chaisson

  • Nothing to Disclose

Nathan G. Fritts

  • Nothing to Disclose

Cicek Gercel-Taylor

  • Patents/Royalties
    Patent as inventor on patent for isolation and identification of brain-derived exosomes

Tsuneya Ikezu

  • Nothing to Disclose

James A. Joyce

  • Equity:
    I own 72,000 common shares and 157,143 stock purchase options in Aethlon Medical, Inc., a publicly traded company, which has majority ownership of Exosome Sciences, Inc.

Brett Martin

  • Nothing to Disclose

Sahil Shah

  • Nothing to Disclose

Robert Stern

  • Consulting Fees:
    I am a paid advisory board member for: Avanir Pharmaceuticals, Amarantus Bioscience, and (upcoming) Biogen. I have also received consulting fees from attorneys representing collegiate athletes.
    Patents/Royalties
    I receive royalties for published neuropsychological tests from Psychological Assessment Resources, Inc.
    Grants
    • Agency: 
      Avid Radiopharmaceuticals (additional study)
      Dates: 
      2014-Present
    • Agency: 
      Eli Lilly
      Dates: 
      2014-Present
    • Agency: 
      Amarantus Holdings
      Dates: 
      2014-Present
    • Agency: 
      Eisai Inc
      Dates: 
      2013-Present

Douglas D. Taylor

  • Patents/Royalties
    Have a patent on the isolation and detection of brain-derived exsosmes.

Yorghos Tripodis

  • Nothing to Disclose

Jing Zhang

  • Nothing to Disclose